ABOS financials
Acumen Pharmaceuticals (ABOS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ABOS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$123.83M | -$121.33M | -2.00 |
| 2024 | – | – | -$114.02M | -$102.33M | -1.71 |
| 2023 | – | – | -$61.14M | -$52.37M | -1.08 |
| 2022 | – | – | -$45.24M | -$42.86M | -1.06 |
| 2021 | – | – | -$19.58M | -$100.61M | -5.02 |
| 2020 | – | – | -$7.91M | -$7.33M | -17.48 |